Nutriband Inc

General ticker "NTRB" information:

  • Sector: Health Care
  • Industry: Pharmaceuticals
  • Capitalization: $48.8M

Nutriband Inc follows the US Stock Market performance with the rate: 33.5%.

Estimated limits based on current volatility of 4.9%: low 3.89$, high 4.30$

Factors to consider:

  • US accounted for 100.0% of revenue in the fiscal year ended 2023-01-31
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-01-31 to 2026-01-30

  • 2024-01-31 to 2025-01-30 estimated range: [1.55$, 3.89$]
  • 2025-01-30 to 2026-01-30 estimated range: [1.80$, 4.32$]

Financial Metrics affecting the NTRB estimates:

  • Negative: Non-GAAP EPS, $ of -0.62 <= 0.10
  • Negative: Operating profit margin, % of -70.03 <= 1.03
  • Negative: Operating cash flow per share per price, % of -14.12 <= 2.35
  • Negative: negative Net income
  • Negative: Industry operating cash flow per share per price (median), % of -11.39 <= 3.85
  • Positive: Inventory ratio change, % of -2.57 <= -1.03

Similar symbols

Short-term NTRB quotes

Long-term NTRB plot with estimates

Financial data

YTD 2022-01-31 2023-01-31 2024-01-31
Operating Revenue $1.42MM $2.08MM $2.09MM
Operating Expenses $7.53MM $6.55MM $6.96MM
Operating Income $-6.11MM $-4.48MM $-4.87MM
Non-Operating Income $-0.07MM $-0.01MM $-0.61MM
Interest Expense $0.12MM $0.01MM $0.08MM
R&D Expense $0.41MM $0.98MM $1.96MM
Income(Loss) $-6.18MM $-4.48MM $-5.49MM
Profit(Loss) $-6.18MM $-4.48MM $-5.49MM
Stockholders Equity $11.86MM $8.57MM $6.44MM
Inventory $0.13MM $0.23MM $0.17MM
Assets $12.74MM $9.46MM $7.52MM
Operating Cash Flow $-2.81MM $-2.99MM $-3.53MM
Capital expenditure $0.08MM $0.08MM $0.05MM
Investing Cash Flow $-0.08MM $-0.08MM $-0.05MM
Financing Cash Flow $7.63MM $0.16MM $2.09MM
Earnings Per Share* $-1.06 $-0.57 $-0.69

* EPS are Split Adjusted, recent splits may be reflected with a delay.